UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

23 Elucidating mechanisms of virulence-enhancing drug-resistance mutations in Pseudomonas aeruginosa

Journal of cystic fibrosis, 2023-10, Vol.22, p.S13-S14

2023

Volltextzugriff (PDF)

499 Determining the molecular underpinnings of virulence-enhancing drug-resistance mutations in Pseudomonas aeruginosa

Journal of cystic fibrosis, 2022-10, Vol.21, p.S282-S282

2022

Volltextzugriff (PDF)

60 Pyochelin-mediated cefiderocol sensitization depends on the FptA transporter

Journal of cystic fibrosis, 2024-09, Vol.23, p.S33-S33

2024

Volltextzugriff (PDF)

WS03.5 Invasive sampling that bypasses the oropharynx provides insights into the lung microbiota of children with CF and mild lung disease

Journal of cystic fibrosis, 2017-06, Vol.16, p.S5-S6

2017

Volltextzugriff (PDF)

101 Pyochelin-overexpressing Pseudomonas aeruginosa mutants evade immune clearance by inducing macrophage ferroptosis

Journal of cystic fibrosis, 2023-10, Vol.22, p.S53-S53

2023

Volltextzugriff (PDF)

74 Inactivating mutations in the MexEFoprN antibiotic efflux pump of Pseudomonas aeruginosa cystic fibrosis clinical isolates enhance virulence

Journal of cystic fibrosis, 2024-09, Vol.23, p.S40-S40

2024

Volltextzugriff (PDF)

49 Bacterial siderophores drive cefiderocol resistance and crossprotection

Journal of cystic fibrosis, 2023-10, Vol.22, p.S26-S27

2023

Volltextzugriff (PDF)

504 Pseudomonas aeruginosa populations in synthetic cystic fibrosis media evolve cooperative behavior in response to cefiderocol pressure

Journal of cystic fibrosis, 2022-10, Vol.21, p.S284-S285

2022

Volltextzugriff (PDF)

476 RNase E: A newplayer in Pseudomonas aeruginosa nutritional virulence

Journal of cystic fibrosis, 2022-10, Vol.21, p.S271-S271

2022

Volltextzugriff (PDF)

WS02.4 Short-term and long-term effects of ivacaftor treatment on sputum microbiota in people with the G551D CFTR mutation

Journal of cystic fibrosis, 2015-06, Vol.14, p.S3-S3

2015

Volltextzugriff (PDF)

412: Molecular mechanisms of cefiderocol resistance in Pseudomonas aeruginosa

Journal of cystic fibrosis, 2021-11, Vol.20, p.S194

2021

Volltextzugriff (PDF)

440: Evaluating antimicrobial susceptibility testing methods for the Burkholderia cepacia complex

Journal of cystic fibrosis, 2021-11, Vol.20, p.S207-S208

2021

Volltextzugriff (PDF)

474 Inhibition of the envelope stress response in Pseudomonas aeruginosa is required for bacterial viability

Journal of cystic fibrosis, 2022-10, Vol.21, p.S270-S270

2022

Volltextzugriff (PDF)

70 Evaluation of the ETEST gradient diffusion method for antimicrobial susceptibility testing of the Burkholderia cepacia complex

Journal of cystic fibrosis, 2024-09, Vol.23, p.S38-S38

2024

Volltextzugriff (PDF)

442: The anti-sigma factor MucA is required for viability in Pseudomonas aeruginosa

Journal of cystic fibrosis, 2021-11, Vol.20, p.S208

2021

Volltextzugriff (PDF)

454: Detecting novel antibiotic resistance mutations in the Burkholderia cepacia complex using machine learning

Journal of cystic fibrosis, 2021-11, Vol.20, p.S214-S215

2021

Volltextzugriff (PDF)

74 Intracellular Pseudomonas aeruginosa in cystic fibrosis lung tissues

Journal of cystic fibrosis, 2023-10, Vol.22, p.S39-S39

2023

Volltextzugriff (PDF)

429: Effects of elexacaftor/tezacaftor/ivacaftor on the CF sputum microbiome: Preliminary analysis from the Promise study

Journal of cystic fibrosis, 2021-11, Vol.20, p.S201-S202

2021

Volltextzugriff (PDF)

EPS6.04 Elexacaftor/tezacaftor/ivacaftor (ETI) reduces sputum pathogen density and lung inflammation, but infection and inflammation persist

Journal of cystic fibrosis, 2023-06, Vol.22, p.S53-S53

2023

Volltextzugriff (PDF)

B16 CYSTIC FIBROSIS (CF) AND NON-CF BRONCHIECTASIS: Short-Term And Long-Term Effects Of Ivacaftor Treatment On Sputum Microbiota In Cf Patients With The G551d Cftr Mutation

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist

The Journal of clinical investigation, 2023-05, Vol.133 (10), p.1-16

2023

Volltextzugriff (PDF)

Bacterial fight-and-flight responses enhance virulence in a polymicrobial infection

Proceedings of the National Academy of Sciences - PNAS, 2014-05, Vol.111 (21), p.7819-7824

2014

Volltextzugriff (PDF)

A compensatory RNase E variation increases Iron Piracy and Virulence in multidrug-resistant Pseudomonas aeruginosa during Macrophage infection

PLoS pathogens, 2023-04, Vol.19 (4), p.e1010942-e1010942

2023

Volltextzugriff (PDF)

Pseudomonas aeruginosa mexR and mexEF Antibiotic Efflux Pump Variants Exhibit Increased Virulence

Antibiotics (Basel), 2021-09, Vol.10 (10), p.1164

2021

Volltextzugriff (PDF)

Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis

Cell reports (Cambridge), 2019-04, Vol.27 (4), p.1190-1204.e3

2019

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(26)
Ingenta
(23)
Elsevier ScienceDirect Journals Complete
(19)
MEDLINE
(4)
IngentaConnect Journals
(3)
Journals@Ovid Complete
(2)
NUS Single-Journal Subscriptions
(2)
JSTOR Complete Journals
(1)

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

23 Elucidating mechanisms of virulence-enhancing drug-resistance mutations in Pseudomonas aeruginosa

499 Determining the molecular underpinnings of virulence-enhancing drug-resistance mutations in Pseudomonas aeruginosa

60 Pyochelin-mediated cefiderocol sensitization depends on the FptA transporter

WS03.5 Invasive sampling that bypasses the oropharynx provides insights into the lung microbiota of children with CF and mild lung disease

101 Pyochelin-overexpressing Pseudomonas aeruginosa mutants evade immune clearance by inducing macrophage ferroptosis

74 Inactivating mutations in the MexEFoprN antibiotic efflux pump of Pseudomonas aeruginosa cystic fibrosis clinical isolates enhance virulence

49 Bacterial siderophores drive cefiderocol resistance and crossprotection

504 Pseudomonas aeruginosa populations in synthetic cystic fibrosis media evolve cooperative behavior in response to cefiderocol pressure

476 RNase E: A newplayer in Pseudomonas aeruginosa nutritional virulence

WS02.4 Short-term and long-term effects of ivacaftor treatment on sputum microbiota in people with the G551D CFTR mutation

412: Molecular mechanisms of cefiderocol resistance in Pseudomonas aeruginosa

440: Evaluating antimicrobial susceptibility testing methods for the Burkholderia cepacia complex

474 Inhibition of the envelope stress response in Pseudomonas aeruginosa is required for bacterial viability

70 Evaluation of the ETEST gradient diffusion method for antimicrobial susceptibility testing of the Burkholderia cepacia complex

442: The anti-sigma factor MucA is required for viability in Pseudomonas aeruginosa

454: Detecting novel antibiotic resistance mutations in the Burkholderia cepacia complex using machine learning

74 Intracellular Pseudomonas aeruginosa in cystic fibrosis lung tissues

429: Effects of elexacaftor/tezacaftor/ivacaftor on the CF sputum microbiome: Preliminary analysis from the Promise study

EPS6.04 Elexacaftor/tezacaftor/ivacaftor (ETI) reduces sputum pathogen density and lung inflammation, but infection and inflammation persist

B16 CYSTIC FIBROSIS (CF) AND NON-CF BRONCHIECTASIS: Short-Term And Long-Term Effects Of Ivacaftor Treatment On Sputum Microbiota In Cf Patients With The G551d Cftr Mutation

Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist

Bacterial fight-and-flight responses enhance virulence in a polymicrobial infection

A compensatory RNase E variation increases Iron Piracy and Virulence in multidrug-resistant Pseudomonas aeruginosa during Macrophage infection

Pseudomonas aeruginosa mexR and mexEF Antibiotic Efflux Pump Variants Exhibit Increased Virulence

Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis

Suchergebnisse filtern